0001437749-23-014701.txt : 20230515 0001437749-23-014701.hdr.sgml : 20230515 20230515185304 ACCESSION NUMBER: 0001437749-23-014701 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230511 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Garlikov Julie CENTRAL INDEX KEY: 0001793266 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33678 FILM NUMBER: 23925025 MAIL ADDRESS: STREET 1: 2420 17TH STREET STREET 2: SUITE 220 CITY: DENVER STATE: CO ZIP: 80202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001389545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680454536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 899-8800 MAIL ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 rdgdoc.xml FORM 4 X0407 4 2023-05-11 0001389545 NovaBay Pharmaceuticals, Inc. NBY 0001793266 Garlikov Julie C/O NOVABAY PHARMACEUTICALS, INC. 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 1 0 Common Stock 2023-05-11 4 M 0 858 A 858 D Restricted Stock Units 2023-05-11 4 M 0 858 0 D Common Stock 858 0 D On November 15, 2022, NovaBay Pharmaceuticals, Inc. effected a 1-for-35 reverse stock split of its common stock, which is reflected in the number of shares. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. /s/ Justin Hall as attorney in fact for Julie Garlikov 2023-05-15